MESO
Mesoblast Ltd
NASDAQ: MESO · HEALTHCARE · BIOTECHNOLOGY
$15.55
+2.17% today
Updated 2026-04-29
Market cap
$2.01B
P/E ratio
—
P/S ratio
30.75x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$10 – $22
Volume
0.3M
Mesoblast Ltd (MESO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.18M | $-9.10M | $-6.20M | $-9.24M | $-9.66M | $108.23M | $-72.12M | $-54.08M | $-81.86M | $-121.71M | $-88.00M | $-95.47M | $-75.01M | $-57.79M | $-56.37M | $-106.68M | $-65.78M | $-63.27M | $-48.46M | $-49.95M |
| Capital expenditures | $153480.00 | $181852.00 | $100956.00 | $170020.00 | $87113.00 | $461549.00 | $2.71M | $2.84M | $37.92M | $2.72M | $922000.00 | $311000.00 | $201000.00 | $279000.00 | $2.25M | $1.65M | $232000.00 | $314000.00 | $331000.00 | $730000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.00M | $547850.00 | $1.35M | $1.20M | $1.02M | $3.30M | $12.12M | $12.29M | $9.42M | $8.57M | $3.39M | $5.28M | $6.20M | $4.37M | $7.52M | $12.51M | $5.54M | $3.65M | $5.87M | $22.09M |
| Free cash flow | $-3.34M | $-9.28M | $-6.30M | $-9.41M | $-9.74M | $107.77M | $-74.82M | $-56.92M | $-119.78M | $-124.42M | $-88.92M | $-95.78M | $-75.21M | $-58.07M | $-58.61M | $-108.33M | $-66.01M | $-63.58M | $-48.79M | $-50.68M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |